CN101357152A - Epiphyllum oxypetalum medicinal preparation - Google Patents
Epiphyllum oxypetalum medicinal preparation Download PDFInfo
- Publication number
- CN101357152A CN101357152A CNA2007100707652A CN200710070765A CN101357152A CN 101357152 A CN101357152 A CN 101357152A CN A2007100707652 A CNA2007100707652 A CN A2007100707652A CN 200710070765 A CN200710070765 A CN 200710070765A CN 101357152 A CN101357152 A CN 101357152A
- Authority
- CN
- China
- Prior art keywords
- examples
- medicine
- flos epiphylli
- epiphylli oxypetali
- medicinal preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a pharmaceutical preparation of night-blooming cereus which belongs to cactaceae, and a use of the night-blooming cereus as a preparation of the invention in drugs used for treating the following diseases: viral hepatitis, cholecystitis, cancer, cholelithiasis, renal calculus and urinary lithiasis, dysmenorrhea, gynecological inflammation, freckles (anti-free radical), hyperlipemia and hypercholesterolemia.
Description
The present invention relates to tcm field, relate in particular to the new purposes of the flower pesticide thing preparation of Flos Epiphylli Oxypetali plant.
The Flos Epiphylli Oxypetali base was the flower of Cactaceae plant Flos Epiphylli Oxypetali originally.
Former plant: Flos Epiphylli Oxypetali Epiphyllum oxypetalum Hew, want the colored Flos Epiphylli Oxypetali of Flos Epiphylli Oxypetali plant to have lung heat clearing, relieving cough and resolving phlegm according to " Chinese medicine voluminous dictionary " introduction, it is painful to control heart gastric qi, spits blood to be suitable for treating pulmonary tuberculosis most.Other document is not seen the clinical function of removing in addition.
The objective of the invention is to provide the new medicinal application field of Flos Epiphylli Oxypetali.
The present invention makes the medicine that the Flos Epiphylli Oxypetali agent is treatment cholecystitis, viral hepatitis, cancer, gallbladder, kidney lithangiuria, dysmenorrhea, gynecological inflammation.
The pharmaceutical preparation of the present invention application in speckle (free radical resisting), hyperlipidemia, the hypercholesterolemia medicine that also is to dispel.
Following examples but the method that is not limited to this is described medicine tool of the present invention clinical practice widely and clinical therapeutic efficacy.
The technological process of medicine system Flos Epiphylli Oxypetali of the present invention agent can be such: the cream → packing etc. of squeezing the juice → decoct → concentrate → receive.
(1) the bright product of the colored Flos Epiphylli Oxypetali of Flos Epiphylli Oxypetali plant are 100 kilograms, squeeze colored juice after cleaning, and its slag decocts with water 2～3 times, and each 2～3 hours, the leaching decocting liquid, the squeezing medicinal residues, pressed liquor and filtrate merge, and leave standstill, and clean with suitable filter filter, it is standby to merge flower juice and decocting liquid.
(2) concentrate: above-mentioned filtrate heating is concentrated into the relative density of regulation, or concentrates drop on mulberry paper to stir to dip in while hot to get, degree of being when not having the water seepage mark around the drop promptly gets " clear paste ", its relative density 1.20-1.25.
(3) receive cream: qinghuo reagent adds its refined honey of 3 times.Along with the increase of denseness, heating-up temperature can correspondingly reduce, and need constantly stir and remove the floating foam on the liquid level when receiving cream.Receive the cream denseness and decide on kind, general relative density is about 1.4.
The relative density whether clear paste that judgement is being heated and finished product cream reach regulation is used the U.S. instrumentation amount of mother-in-law usually.Because of the denseness of cream is big, the scale of the U.S. meter of mother-in-law is difficult for being certain about, and simultaneously, the standard temperature of the U.S. meter of mother-in-law is 20 ℃, so, as follows with the relative density method of the U.S. instrumentation of mother-in-law " receipts cream ":
The water 400ml of accurately measuring 15 ℃～30 ℃ puts in the 500ml graduated cylinder, just drips at spissated thick paste to 500ml, after stirring evenly, with U.S. its relative density numerical value of instrumentation of mother-in-law, tries to achieve the relative density of thick paste by (7-1) formula:
For example: the above-mentioned thick paste that is diluted to 5 times, recording mother-in-law U.S. degree is 10.7, then the relative density of this thick paste is 1.40.
(4) packing: after treating that soft extracts fully cools off, be sub-packed in again in clean (or sterilization) exsiccant heavy caliber container, cover completely, in order to avoid mildew is rotten.(it is the most suitable that clinical large tracts of land popularization can be processed as this thick paste soft capsule).
[function with cure mainly] viral hepatitis, cholecystitis, cancer, gallbladder, kidney lithangiuria, dysmenorrhea, gynecological inflammation, and free radical resisting, hyperlipidemia, hypercholesterolemia effect.
[usage and dosage] is oral, a 10ml, 1-2 time on the one.
Below be the clinical effectiveness of medicine of the present invention to following illness.
1, medicine of the present invention is to the clinical efficacy of hepatitis (acute viral hepatitis 13 examples, active migration chronic hepatitis 38 examples).
Cure (cardinal symptom disappears, and the liver spleen recovers normal or obvious retraction, and the hepatic region does not have obvious tenderness or percussion pain, and below the SGPT40 unit, HBSAg is cloudy to be changeed) 23 examples, account for 45%.
Produce effects (cardinal symptom obviously alleviates, the normal or retraction of liver spleen, and hepatic region tenderness or percussion pain obviously alleviate, liver function is normal substantially) 22 examples, account for 43%.
Take a turn for the better (cardinal symptom obviously alleviates, liver and spleen retraction, and hepatic region tenderness percussion pain alleviates, liver function is near normal) 6 examples, account for 12%.
2, medicine of the present invention is treated 67 examples to the cystolithic clinical efficacy of cholecystitis gallbladder kidney.(wherein simple property cholecystitis 17 examples, cholelithiasis 14 examples of holding concurrently)
The basic healing (the ultrasound diagnosis calculus is discharged, and right upper quadrant of the abdomen pain disappears, and follows up a case by regular visits to not morbidity more than half in 1 year) 26 examples.
Produce effects (B ultrasonic check calculus is partly discharged, and the upper right abdomen or the side of body paroxysmal pain down disappear, and the dull pain idol is done, and follows up a case by regular visits to not morbidity more than half a year) 33 examples.
(B ultrasonic check calculus is not discharged, and paroxysmal pain disappears, and the dull pain number of times reduces, and follows up a case by regular visits to not morbidity more than 3 months) 8 examples take a turn for the better.
3, medicine of the present invention is treated 76 examples to the clinical efficacy of gynecological inflammation, 62 examples of fully recovering, and 14 examples take a turn for the better.Cervicitis 27 examples wherein, pelvic inflammatory disease 33 examples, colpitis mycotica patient's 19 examples, trichomonal vaginitis person 7 examples.
4, medicine of the present invention is to 65 routine dysmenorrhea patient's clinical efficacies.
Recovery from illness (stomachache reaches with transference cure) 34 examples account for 48.57%; Improvement (the stomachache degree alleviates, and the time shortens, and accompanies out with remission) 31 examples account for 44.29%.
5, Drug therapy cervical cancer 12 examples of the present invention, breast carcinoma 7 examples (II phases 4 example, III phases 11 example, IV phases 4 example), through Drug therapy 2-4 of the present invention month, the cachexia sign alleviated blood serum designated object and descends, and stomach is received body weight obviously to be increased, and the state of an illness takes a favorable turn.
Claims (2)
1, the application of Flos Epiphylli Oxypetali in preparation treatment cholecystitis, gallstones and kidney stones, hepatitis, cancer, dysmenorrhea, gynecological inflammation medicine.
2, the application of Flos Epiphylli Oxypetali in preparation treatment hyperlipidemia, hypercholesterolemia and free radical resisting (speckle of dispelling) medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100707652A CN101357152A (en) | 2007-08-04 | 2007-08-04 | Epiphyllum oxypetalum medicinal preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100707652A CN101357152A (en) | 2007-08-04 | 2007-08-04 | Epiphyllum oxypetalum medicinal preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101357152A true CN101357152A (en) | 2009-02-04 |
Family
ID=40329838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100707652A Pending CN101357152A (en) | 2007-08-04 | 2007-08-04 | Epiphyllum oxypetalum medicinal preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101357152A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840604A (en) * | 2015-06-17 | 2015-08-19 | 产俊涛 | Traditional Chinese medicine composition for treating pelvic inflammation as well as preparation and use of traditional Chinese medicine composition |
| CN104857063A (en) * | 2015-06-17 | 2015-08-26 | 产俊涛 | Traditional Chinese medicine composition for treating liver cancer and application thereof |
| CN104940410A (en) * | 2015-07-21 | 2015-09-30 | 陈�峰 | Traditional Chinese medicine composition for treating cervicitis and preparation method and application thereof |
| CN104940267A (en) * | 2015-07-21 | 2015-09-30 | 陈�峰 | Traditional Chinese medicine combination for treating hepatitis and application thereof |
-
2007
- 2007-08-04 CN CNA2007100707652A patent/CN101357152A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104840604A (en) * | 2015-06-17 | 2015-08-19 | 产俊涛 | Traditional Chinese medicine composition for treating pelvic inflammation as well as preparation and use of traditional Chinese medicine composition |
| CN104857063A (en) * | 2015-06-17 | 2015-08-26 | 产俊涛 | Traditional Chinese medicine composition for treating liver cancer and application thereof |
| CN104940410A (en) * | 2015-07-21 | 2015-09-30 | 陈�峰 | Traditional Chinese medicine composition for treating cervicitis and preparation method and application thereof |
| CN104940267A (en) * | 2015-07-21 | 2015-09-30 | 陈�峰 | Traditional Chinese medicine combination for treating hepatitis and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101428086B (en) | Traditional Chinese medicine preparation for treating peptic ulcer and preparation method thereof | |
| CN105125407B (en) | A kind of decocting container | |
| CN206404366U (en) | A kind of traditional Chinese medicine liquid extraction equipment | |
| CN1306818A (en) | Medicine for treating abacterial inflammation and its extraction method | |
| CN101357152A (en) | Epiphyllum oxypetalum medicinal preparation | |
| CN104415290A (en) | Stagnation-removing decoction oral liquid and preparation method thereof | |
| CN1344547A (en) | Multieffect stomach-invigorating bolus | |
| CN104857436B (en) | Traditional Chinese medicine compound composition with resisting liver cancer activity and its preparation method and application | |
| CN105497096A (en) | Medicine composition for treating liver ascites and preparation method thereof | |
| CN105056172A (en) | Compound Norfloxacin slow-release capsules and preparing method thereof | |
| CN102091288A (en) | Chinese medicine preparation for treating fatty liver and preparation method thereof | |
| CN105012911A (en) | Compound norfloxacin composition and preparation method | |
| CN103893611A (en) | Drug for treating kidney stone and preparation method of drug | |
| CN107149653A (en) | A kind of Traditional Chinese medicine compound composition with antitumor activity and its preparation method and application | |
| CN103638447B (en) | A kind of Chinese medicine composition and application thereof for the treatment of cholecystitis | |
| CN107875211A (en) | It is a kind of to be used to treat composition of ulcerative colitis and its preparation method and application | |
| CN1114418C (en) | Medicine for rheumatism and aploplexy and its preparation | |
| CN103800717A (en) | Traditional Chinese medicine for treating pyelonephritis and preparation method thereof | |
| CN104840748B (en) | Chinese medicine composition with anti-cancer of the brain activity and its preparation method and application | |
| CN206621823U (en) | A kind of medical hydrochloric acid liquid medicine extraction element | |
| CN209612264U (en) | A kind of traditional Chinese medicine extraction device | |
| CN102940674B (en) | Medicine composition for treating benign prostatic hyperplasia | |
| CN109419903A (en) | A kind of herbal retention enema liquid for treating gynaecological imflammation | |
| CN105727321A (en) | Traditional Chinese medicine assisted development contrast medium for ultrasonic diagnosis | |
| CN105497755A (en) | Erbao concentrated decoction for treating infantile anorexia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20090204 |